Blog

Mary Schubauer-Berigan: Exceptional contributions from our 30 Working Group members who spent more than one year thoroughly evaluating the carcinogenicity of PFOA and PFOS

Photo taken from Mary Schubauer-Berigan/LinkedIn

Dec 6, 2023, 16:15

Mary Schubauer-Berigan: Exceptional contributions from our 30 Working Group members who spent more than one year thoroughly evaluating the carcinogenicity of PFOA and PFOS

Mary Schubauer-Berigan, Head of the Monographs Programme at the International Agency for Research on Cancer, shared IARC’s post on X/Twitter adding:

“Exceptional contributions from our 30 Working Group members who spent more than 1 year thoroughly evaluating the carcinogenicity of PFOA and PFOS.”

Quoting IARC‘s post below:

“The IARC Monographs programme has evaluated the carcinogenicity of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and classified PFOA as carcinogenic to humans (Group 1) and PFOS as possibly carcinogenic to humans (Group 2B)”

Sources: Mary Schubauer-Berigan/X and IARC/X

cancer carcinogenicity IARC Mary Schubauer-Berigan OncoDaily Oncology perfluorooctanesulfonic acid (PFOS) perfluorooctanoic acid (PFOA) Working Groups

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage